Fairhaven Wealth Management, LLC Amgen Inc Transaction History

Fairhaven Wealth Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$198.88 - $227.6 $264,112 - $302,252	-1,328 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$233.58 - $259.14 $6,073 - $6,737	-26 Reduced 1.92%	1,328 $324,000
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $9,520 - $11,337	44 Added 3.36%	1,354 $311,000
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $59,145 - $72,579	299 Added 29.57%	1,310 $309,000
Q1 2020 May 05, 2020	SELL	$182.24 - $241.7 $41,004 - $54,382	-225 Reduced 18.2%	1,011 $205,000
Q4 2019 Feb 07, 2020	SELL	$189.21 - $243.2 $31,030 - $39,884	-164 Reduced 11.71%	1,236 $298,000
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $22,504 - $26,380	135 Added 10.67%	1,400 $258,000
Q1 2019 Apr 19, 2019	BUY	$180.87 - $203.88 $33,460 - $37,717	185 Added 17.13%	1,265 $240,000
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $192,672 - $224,910	1,080 New	1,080 $210,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Fairhaven Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fairhaven Wealth Management, LLC with notifications on news.